// App-Quantinova.ai

444 : Hyaluronan-mediated motility receptor (RHAMM) in ovarian cancer

Researchers

Presenter

  • Stephanie Buttermore

Principal Investigators

  • Patricia Kruk

Medical Centers

  • University of South Florida, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Receptor for hyaluronic acid mediated motility

Drug/Treatment

  • Hyaluronic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved